For price transparency, the eagle has landed; on Friday, November 15, the Trump administration releases final and major price transparency regulations. HHS views price transparency as a matter it can address through de novo regulation, whereas most surprise billing issue fall outside of Medicare or Medicaid and would require legislation.
Somewhat confusingly, today's release is a second part to the annual OPPS final rule, most of which was released November 1 (here). In that rule, CMS merely stated concisely that "We intend to [issue] a forthcoming final rule."
- For CMS/HHS press release, here.
- For CMS fact sheet on the rule (CMS-1717-F2), here.
- For the actual rule (in typescript form, 331pp), here.
- For WSJ article, here.
- For a September background WSJ article, here. ("Push Sparks Furor")